	Name	Value
	Revenue (TTM) (Mil Rp)
	EPS (TTM) (Rp)	0
	Beta	0
	Volatility %	46.58
	14-Day RSI	41.07
	14-Day ATR (Rp)	0.000007
	20-Day SMA (Rp)	50
	12-1 Month Momentum %	0
	52-Week Range (Rp)	50 - 91
	Shares Outstanding (Mil)	1,562.5

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	9999
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

PT Hetzer Medical Indonesia Tbk Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

PT Hetzer Medical Indonesia Tbk Stock Events

Financials Calendars

	Event	Date	Price(Rp)
No Event Data

PT Hetzer Medical Indonesia Tbk Frequently Asked Questions

What is PT Hetzer Medical Indonesia Tbk(ISX:MEDS)'s stock price today?

The current price of ISX:MEDS is Rp50.00. The 52 week high of ISX:MEDS is Rp91.00 and 52 week low is Rp50.00.

When is next earnings date of PT Hetzer Medical Indonesia Tbk(ISX:MEDS)?

The next earnings date of PT Hetzer Medical Indonesia Tbk(ISX:MEDS) is .

Does PT Hetzer Medical Indonesia Tbk(ISX:MEDS) pay dividends? If so, how much?

PT Hetzer Medical Indonesia Tbk(ISX:MEDS) does not pay dividend.

Press Release

	Subject	Date
No Press Release

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.